Treatment of SARS with human interferons

Mostrar otras versiones (1)

Effective antiviral agents are needed to treat severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infection. We assessed the antiviral potential of recombinant interferons against two clinical isolates of SARS-CoV—FFM-1, from Frankfurt patients, and Hong Kong—replicated in Vero and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cinatl, J, Morgenstern, B, Bauer, G, Chandra, P, Rabenau, H, Doerr, HW
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2003
Materias:
Fast track — Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112413/
https://www.ncbi.nlm.nih.gov/pubmed/12892961
http://dx.doi.org/10.1016/S0140-6736(03)13973-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112413/
https://www.ncbi.nlm.nih.gov/pubmed/12892961
http://dx.doi.org/10.1016/S0140-6736(03)13973-6

Ejemplares similares